Liu Quanda, Ma Kuansheng, Song Yang, Zhou Ningxin, He Zhenping
Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, China.
Surgery. 2008 Apr;143(4):509-18. doi: 10.1016/j.surg.2007.11.016. Epub 2008 Jan 30.
Hepatocyte hypoxia may be a mechanism determining abnormal tissue oxygenation and dysfunction of the cirrhotic liver. Since the introduction of radiofrequency ablation (RFA) for patients with cirrhotic hypersplenism, we observed a phenomenon of visible hepatic regeneration. This study aims to investigate the potential mechanism of RFA-induced liver regeneration, and the 2-year outcomes of splenic RFA.
Forty patients who underwent splenic RFA for cirrhotic hypersplenism were followed for 24 months. Before and after RFA procedures, portal hemodynamics and liver and spleen volumes were measured by Doppler ultrasonography and computed tomography volumetry. Liver function tests and blood counts were also determined.
The splenic and portal venous flows decreased, but hepatic arterial flow (HAF) increased dramatically after the RFA procedure. Liver volumes at 3 month post-RFA increased compared to the baseline volumes (872 +/- 107 vs. 821 +/- 99 cm(3), P = .031). A correlation was found between maximum absolute values of liver volumes (triangle upliver volumes) and that of HAF (triangle upHAF) in Child-Pugh class A/B patients (r = 0.60; P < .001). Leukocyte and platelet counts, as well as liver function, improved substantially during the 2-year follow-up. Patients with > or = 40% of spleen volume ablated had better improvement of thrombocytopenia. No death or severe complications occurred.
RFA for cirrhotic hypersplenism is safe and efficacious. The increase in HAF as a result of splenic RFA may improve liver function and induce liver regeneration in cirrhotics, but further studies are necessary to clarify the underlying mechanisms.
肝细胞缺氧可能是决定肝硬化肝脏组织氧合异常和功能障碍的一种机制。自从对肝硬化脾功能亢进患者引入射频消融术(RFA)以来,我们观察到了明显的肝脏再生现象。本研究旨在探讨RFA诱导肝脏再生的潜在机制以及脾脏RFA的2年疗效。
对40例行脾脏RFA治疗肝硬化脾功能亢进的患者进行了24个月的随访。在RFA手术前后,通过多普勒超声和计算机断层扫描容积测量法测量门静脉血流动力学以及肝脏和脾脏体积。还进行了肝功能检查和血细胞计数。
RFA术后脾静脉和门静脉血流减少,但肝动脉血流(HAF)显著增加。与基线体积相比,RFA术后3个月时肝脏体积增加(872±107 vs. 821±99 cm³,P = 0.031)。在Child-Pugh A/B级患者中,肝脏体积的最大绝对值(△肝脏体积)与HAF的最大绝对值(△HAF)之间存在相关性(r = 0.60;P < 0.001)。在2年的随访期间,白细胞和血小板计数以及肝功能显著改善。脾脏体积消融≥40%的患者血小板减少症改善更佳。未发生死亡或严重并发症。
RFA治疗肝硬化脾功能亢进安全有效。脾脏RFA导致的HAF增加可能改善肝硬化患者的肝功能并诱导肝脏再生,但需要进一步研究以阐明潜在机制。